Hyperkalemic periodic paralysis and paramyotonia congenita caused by a de novo mutation in the SCN4A gene

Neurology Asia

Volumn 16, Issue 2, 2011, Pages 163-166

  Lee, Gyung Min ^a   Kim, June Bum ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CREATINE KINASE; GLUCOSE; INSULIN; POTASSIUM; POTASSIUM CHLORIDE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DIET RESTRICTION; ELECTROMYOGRAPHY; FACE MUSCLE; GENE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; INDUCED HYPOTHERMIA; LIMB WEAKNESS; MALE; MUSCLE RIGIDITY; MUSCLE WEAKNESS; NUCLEIC ACID BASE SUBSTITUTION; ONSET AGE; OUTPATIENT; PERIODIC PARALYSIS; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; POTASSIUM RESTRICTION; PROVOCATION TEST; SCN4A GENE; SKELETAL MUSCLE; THOMSEN DISEASE;

EID: 79960537003     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ptacek LJ, George AL, Jr., Griggs RC, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991; 67:1021-7.
2. Davies NP, Hanna MG. The skeletal muscle ion channelopathies: basic science, clinical genetics and treatment. Curr Opinion Neurol 2001; 14:539-51.
3. Jurkat-Rott K, Lehmann-Horn F. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics 2007; 4:216-24.
4. Brancati F, Valente EM, Davies NP, et al. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry 2003; 74:1339-41.
5. Bendahhou S, Cummins TR, Tawil R, et al. Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. J Neurosci 1999; 19:4762-71.
6. Bendahhou S, Cummins TR, Hahn AF, et al. A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation. J Clin Invest 2000; 106:431-8.
7. Bendahhou S, Cummins TR, Kula RW, et al. Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5. Neurology 2002; 58:1266-72.
8. Hsu WC, Huang YC, Wang YC, Wang CW, et al. Paralysis periodica paramyotonica caused by SCN4A Arg1448Cys mutation. 2006; 105:503-7.
9. Griggs RC, Mendell JR, Miller RG. Evaluation and treatment of myopathies. Philadelphia: FA Davis, 1995: 318-32.
10. Park YH, Kim JB. An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the sodium channel gene SCN4A. Korean J Pediatr 2010; 53:909-12.
11. Plassart E, Eymard B, Maurs L, et al. Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene. J Neurol Sci 1996; 142:126-33.
12. Ricker K, Böhlen R, Rohkamm R. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Neurology 1983; 33:1615-8.